AIM ImmunoTech, Inc. (AIM)
0.2297
0.00 (0.00%)
USD |
NYAM |
Sep 08, 16:00
0.2297
0.00 (0.00%)
Pre-Market: 09:09
AIM ImmunoTech Profit Margin (Quarterly) : -14.57K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.57K% |
| March 31, 2026 | -13.74K% |
| December 31, 2025 | -19.88K% |
| September 30, 2025 | -12.63K% |
| June 30, 2025 | -11.18K% |
| March 31, 2025 | -23.16K% |
| December 31, 2024 | -13.26K% |
| September 30, 2024 | -10.57K% |
| June 30, 2024 | -3.67K% |
| March 31, 2024 | -14.54K% |
| December 31, 2023 | -19.35K% |
| September 30, 2023 | -16.99K% |
| June 30, 2023 | -11.69K% |
| March 31, 2023 | -7.47K% |
| December 31, 2022 | -7.84K% |
| September 30, 2022 | -30.40K% |
| June 30, 2022 | -16.17K% |
| March 31, 2022 | -11.58K% |
| December 31, 2021 | -11.69K% |
| September 30, 2021 | -11.59K% |
| June 30, 2021 | -25.55K% |
| March 31, 2021 | -12.78K% |
| December 31, 2020 | -9.37K% |
| September 30, 2020 | -9.18K% |
| June 30, 2020 | -8.42K% |
| Date | Value |
|---|---|
| March 31, 2020 | -8.46K% |
| December 31, 2019 | -2.13K% |
| September 30, 2019 | -4.83K% |
| June 30, 2019 | -7.02K% |
| March 31, 2019 | |
| December 31, 2018 | -669.6% |
| September 30, 2018 | -8.10K% |
| June 30, 2018 | -7.32K% |
| March 31, 2018 | -4.84K% |
| December 31, 2017 | -3.99K% |
| September 30, 2017 | -1.39K% |
| June 30, 2017 | -1.03K% |
| March 31, 2017 | -3.36K% |
| December 31, 2016 | -7.33K% |
| September 30, 2016 | -13.01K% |
| June 30, 2016 | -8.69K% |
| March 31, 2016 | -5.55K% |
| December 31, 2015 | -11.62K% |
| September 30, 2015 | -16.53K% |
| June 30, 2015 | -10.31K% |
| March 31, 2015 | -9.57K% |
| December 31, 2014 | -11.14K% |
| September 30, 2014 | -9.34K% |
| June 30, 2014 | -13.77K% |
| March 31, 2014 | -5.05K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
| Savara, Inc. | -- |
| Vericel Corp. | 2.85% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -194.3% |
| Return on Invested Capital | -1.19K% |
| Gross Profit Margin (Quarterly) | -1.95K% |
| Operating Margin (Quarterly) | -13.42K% |
| Return on Net Operating Assets | -620.9% |